14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
HLIT vs CAMP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Harmonic Inc (HLIT) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLIT carries a Unified Composite Score of 54.4/100 (HOLD) at $10.20 (11.3x Forward P/E, 14.8% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin).
Growth vs. Quality Trade-Off: HLIT earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. CAMP 43.9/100 HOLD) and 2.10β · 56% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: HLIT is currently in a Breakdown options structure phase (RSI 47.2); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ HLIT vs CAMP Key Questions & Quantitative Answers
As of Nov 17, 2026, Harmonic Inc (HLIT) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLIT carries a Unified Composite Score of 54.4/100 (HOLD) at $10.20 (11.3x Forward P/E, 14.8% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin). Growth vs. Quality Trade-Off: HLIT earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. CAMP 43.9/100 HOLD) and 2.10β · 56% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HLIT is currently in a Breakdown options structure phase (RSI 47.2); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HLIT leads the Growth & Scale pillar: HLIT posts +64.5% YoY revenue growth and +543.3% YoY earnings growth on $502M TTM revenue (51.1% gross margin, 14.8% operating margin), compared with CAMP at +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HLIT cumulative revenue shifted -10.0% while CAMP shifted N/A. In operating R&D and SG&A reinvestment, HLIT deploys 36.3% of Rev ($182M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CAMP.
HLIT screens cheaper on headline valuation multiples. HLIT trades at 11.3x Forward P/E, 25.2x Trailing P/E, 1.84x PEG, and 2.0x EV/Revenue (5.5% FCF margin), whereas CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HLIT (11.0% ROE) versus CAMP (-146.1% ROE) capital efficiency.
In options market volatility and institutional positioning, HLIT carries 59.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 3.91x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.10β · 56% Vol realized risk). By comparison, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.